These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 474380)

  • 21. Electrophysiologic effects of disopyramide in children.
    Kashani IA; Shakibi JG; Siassi B
    Jpn Heart J; 1980 Jul; 21(4):491-6. PubMed ID: 7420732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.
    Elharrar V; Gaum WE; Zipes DP
    Am J Cardiol; 1977 Apr; 39(4):544-9. PubMed ID: 848439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of alternans of monophasic action potential and conduction delay inside the ischemic border zone to serious ventricular arrhythmia during acute myocardial ischemia in dogs.
    Abe S; Nagamoto Y; Fukuchi Y; Hayakawa T; Kuroiwa A
    Am Heart J; 1989 Jun; 117(6):1223-33. PubMed ID: 2729052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
    Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ
    Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
    Nakamura M; Xue Y; Eto K; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of procainamide on the dispersion of recovery of excitability during coronary occlusion.
    Levites R; Haft JI; Calderon J; Venkatachalapathy
    Circulation; 1976 Jun; 53(6):982-4. PubMed ID: 1269135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac effects of disopyramide.
    Danilo P; Rosen MR
    Am Heart J; 1976 Oct; 92(4):532-6. PubMed ID: 785992
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
    Myers JB; Millar RN; Obel IW
    S Afr Med J; 1978 Dec; 54(26):1083-9. PubMed ID: 746466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular electrophysiological changes during ischemia in isolated, coronary-perfused cat ventricle with healed myocardial infarction.
    Kimura S; Bassett AL; Cameron JS; Huikuri H; Kozlovskis PL; Myerburg RJ
    Circulation; 1988 Aug; 78(2):401-6. PubMed ID: 3396177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts.
    Iwasaki S; Araki H; Yamakawa T; Nishi K; Miyauchi Y
    Arch Int Pharmacodyn Ther; 1989; 300():174-85. PubMed ID: 2619422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].
    Grosu AA
    Kardiologiia; 1985 May; 25(5):114-8. PubMed ID: 3894756
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiologic effects of disopyramide in patients with atrioventricular nodal dysfunction.
    Wilkinson PR; Desai J; Hollister J; Gonzalez R; Abbott JA; Scheinman MM
    Circulation; 1982 Dec; 66(6):1211-6. PubMed ID: 7139899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in canine myocardial excitability during ischemia.
    Elharrar V; Foster PR; Jirak TL; Gaum WE; Zipes DP
    Circ Res; 1977 Jan; 40(1):98-105. PubMed ID: 830442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of premature depolarization on refractoriness of ischemic canine myocardium.
    Burgess MJ; Coyle J
    J Electrocardiol; 1982 Oct; 15(4):335-44. PubMed ID: 6183387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.